SCHEMBL4977264

SCHEMBL4977264

N#CC1(CCO)CCN(C(=O)O)CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.31
OPRL1 P41146 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16415482 0.90 OPRM1 (0.32) OPRM1OPRL1
SCHEMBL16416213 0.85 OPRM1 (0.32) OPRM1OPRL1
SCHEMBL23528023 0.80 CA12 (0.33) OPRM1OPRL1
SCHEMBL2798365 0.77 USP2 (0.43)
SCHEMBL16914443 0.76 OPRM1 (0.30) OPRM1OPRL1
SCHEMBL1818822 0.76 HSD11B1 (0.39) OPRM1OPRL1
SCHEMBL23270082 0.76
SCHEMBL5497668 0.76 CA12 (0.32)
SCHEMBL2202122 0.75 NPC1 (0.33)
SCHEMBL16914465 0.73 OPRM1 (0.36) OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021038-A1 Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5 TUCKER HOWARD 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021038-A1 Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5 CCR5, CXCR1, CCR2 OPRM1 31/4885OPRL1 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.